Opko Health OPK Rayaldee — Valuation Allowances And Reserves Balance
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:ValuationAllowancesAndReservesBalance.
The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opko Health's rayaldee — valuation allowances and reserves balance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opko Health's rayaldee — valuation allowances and reserves balance?
- Opko Health (OPK) reported rayaldee — valuation allowances and reserves balance of $8.47M in Q1 2026.
- How has Opko Health's rayaldee — valuation allowances and reserves balance changed year-over-year?
- Opko Health's rayaldee — valuation allowances and reserves balance increased by 12.1% year-over-year, from $7.56M to $8.47M.
- What is the long-term trend for Opko Health's rayaldee — valuation allowances and reserves balance?
- Over 3 years (2022 to 2025), Opko Health's rayaldee — valuation allowances and reserves balance has grown at a -5.8% compound annual growth rate (CAGR), from $38.1M to $31.86M.
- What does rayaldee — valuation allowances and reserves balance mean?
- The cumulative ending balance of contra-asset accounts established to account for expected reductions in gross revenue, such as sales returns, rebates, or discounts. This balance reflects the estimated financial impact of future adjustments related to current and past sales. Monitoring this helps assess the accuracy of revenue recognition and potential future earnings volatility.